AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECG TM software platform has ...

A procedure has now been performed using Imricor’s 3D mapping system in a prominent Hungarian hospital. ... Read More The ...

Heart rhythm problems aren’t always serious, but they can be signs of something more. Check out the symptoms and if notice ...

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

Personal training is where this story starts. “My trainer had been, for years, suggesting I get an Apple Watch, and I had ...

Pulsed field ablation dominated discussions and scientific sessions at Heart Rhythm 2025 in San Diego with researchers and ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

defined as 12-month freedom from a documented 30-second episode of Afib/atrial flutter/atrial tachycardia, failure of pulmonary vein isolation (PVI), cardioversion, antiarrhythmic drug use ...

Boston Scientific has reported positive 12-month primary endpoint outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse pulsed field ablation (PFA) system and Farapoint PFA ...

A significant proportion of patients undergoing atrial fibrillation (AF) ablation as part of the CABANA trial had a high probability of heart failure with preserved ejection fraction (HFpEF).

The single-arm, prospective trial focused on the Farawave PFA Catheter for pulmonary vein isolation (PVI) and posterior wall ablation (PWA), as well as the Farapoint PFA Catheter for cavotricuspid ...